Literature DB >> 1562460

Induction of myogenic differentiation in human rhabdomyosarcoma cells by ionising radiation, N,N-dimethylformamide and their combination.

G Nicoletti1, C De Giovanni, L Landuzzi, G Simone, P Rocchi, P Nanni, P L Lollini.   

Abstract

Differentiation-inducing ability of gamma-radiation, N,N-dimethylformamide and their combination has been tested on human rhabdomyosarcoma RMZ-RC2 clone cells. Ionising radiation at 2-5 Gy doses induced a more differentiated morphology, with the appearance of an increased proportion of multinuclear myotube-like cells, and a significant increase in myosin-positive and multinuclear cells. Radiation appeared to act by inducing de novo differentiated elements. N,N-dimethylformamide was able to induce an increased myosin expression, but did not affect multinuclear cell proportion. The combined treatment (ionising radiation and N,N-dimethylformamide) resulted in an additive increase in the proportion of myosin-positive cells, approaching 25-35%, but de novo differentiated elements were not increased above the levels obtained with irradiation alone.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1562460      PMCID: PMC1977576          DOI: 10.1038/bjc.1992.107

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  Myogenic differentiation of human rhabdomyosarcoma cells induced in vitro by antineoplastic drugs.

Authors:  P L Lollini; C De Giovanni; B Del Re; L Landuzzi; G Nicoletti; G Prodi; K Scotlandi; P Nanni
Journal:  Cancer Res       Date:  1989-07-01       Impact factor: 12.701

Review 2.  Induction of tumor cell differentiation as a therapeutic approach: preclinical models for hematopoietic and solid neoplasms.

Authors:  M Reiss; C Gamba-Vitalo; A C Sartorelli
Journal:  Cancer Treat Rep       Date:  1986-01

3.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

4.  Alteration of the survival response of two human colon carcinoma subpopulations to x-irradiation by N,N-dimethylformamide.

Authors:  J T Leith; L A Gaskins; D L Dexter; P Calabresi; A S Glicksman
Journal:  Cancer Res       Date:  1982-01       Impact factor: 12.701

5.  Embryonic myosin heavy chain as a differentiation marker of developing human skeletal muscle and rhabdomyosarcoma. A monoclonal antibody study.

Authors:  S Schiaffino; L Gorza; S Sartore; L Saggin; M Carli
Journal:  Exp Cell Res       Date:  1986-03       Impact factor: 3.905

6.  Enhancement of the responses of human colon adenocarcinoma cells to X-irradiation and cis-platinum by N-methylformamide (NMF).

Authors:  J T Leith; E S Lee; A J Vayer; D L Dexter; A S Glicksman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-11       Impact factor: 7.038

7.  N,N-Dimethylformamide-induced morphological differentiation and reduction of tumorigenicity in cultured mouse rhabdomyosarcoma cells.

Authors:  D L Dexter
Journal:  Cancer Res       Date:  1977-09       Impact factor: 12.701

8.  Modification of tumor and normal tissue radioresponse in mice by N-methylformamide.

Authors:  M Iwakawa; L Milas; N Hunter; P J Tofilon
Journal:  Int J Radiat Oncol Biol Phys       Date:  1987-01       Impact factor: 7.038

9.  The in vitro growth, heterotransplantation, and differentiation of a human rhabdomyosarcoma cell line.

Authors:  A J Garvin; W S Stanley; D D Bennett; J L Sullivan; D A Sens
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

10.  Heterogeneous response to differentiation induction with different polar compounds in a clonal rat rhabdomyosarcoma cell line (BA-HAN-1C).

Authors:  C D Gerharz; H E Gabbert; R Engers; U Ramp; H Mayer; C Luley
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640

View more
  3 in total

Review 1.  The role of cell differentiation in controlling cell multiplication and cancer.

Authors:  Karl-Hartmut von Wangenheim; Hans-Peter Peterson
Journal:  J Cancer Res Clin Oncol       Date:  2008-04-15       Impact factor: 4.553

2.  Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: utility and pitfalls.

Authors:  Ashley R P Hinson; Rosanne Jones; Lisa E S Crose; Brian C Belyea; Frederic G Barr; Corinne M Linardic
Journal:  Front Oncol       Date:  2013-07-17       Impact factor: 6.244

3.  Uncoupling of growth inhibition and differentiation in dexamethasone-treated human rhabdomyosarcoma cells.

Authors:  C De Giovanni; P L Lollini; R Dolcetti; L Landuzzi; G Nicoletti; E D'Andrea; K Scotland; P Nanni
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.